Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...
Amgen enters October with fresh Phase 3 pipeline wins, strong growth from Repatha and Imdelltra, and MariTide advancing ...
The 658th General Meeting of the Central Social Insurance Medical Council (Chuikyo) was held on September 30, 2026. While the ...
The FDA has approved Rhapsido (remibrutinib) for adults with symptomatic dermographism who remain symptomatic despite use of ...
4h
Customer's prescription refill surprise sparks flood of tips for paying less for the same medication
Some people said the lowest price could come from skipping insurance. One commenter wrote that they sometimes get medications "for lower costs directly from Publix or Costco if I just buy them without ...
Teva has received FDA approval for once monthly injectable schizophrenia drug Weltruza. The announcement sent Teva shares ...
The FDA has approved an expanded indication for remibrutinib as the first treatment for adults with symptomatic dermographism ...
The FDA has approved olanzapine extended-release injectable suspension (Weltruza; Teva Pharmaceuticals), a once-monthly ...
The FDA approved remibrutinib (Rhapsido; Novartis) today, October 7, 2026, as the first treatment for adults with symptomatic ...
Those looking to pump up their workouts might be getting more than they bargained for. The FDA found that RAPTURE Preworkout ...
During the October 1 episode of Mad Money, Jim Cramer discussed Amgen Inc. (NASDAQ:AMGN) while reviewing the Dow Jones ...
FDA approves Rhapsido (remibrutinib) for symptomatic dermographism, the first prescription treatment for adults with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results